These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 3311559)
21. Development of individual insulin infusion profiles for open loop infusion systems. Strack T; Krause U; Schulz G; Beyer J; Beutelspacher F; Nagel J Horm Metab Res; 1984 Apr; 16(4):163-7. PubMed ID: 6547110 [TBL] [Abstract][Full Text] [Related]
22. Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Steil GM; Rebrin K; Darwin C; Hariri F; Saad MF Diabetes; 2006 Dec; 55(12):3344-50. PubMed ID: 17130478 [TBL] [Abstract][Full Text] [Related]
23. Closed-loop control of artificial pancreatic Beta -cell in type 1 diabetes mellitus using model predictive iterative learning control. Wang Y; Dassau E; Doyle FJ IEEE Trans Biomed Eng; 2010 Feb; 57(2):211-9. PubMed ID: 19527957 [TBL] [Abstract][Full Text] [Related]
24. Insulin kinetics in type-I diabetes: continuous and bolus delivery of rapid acting insulin. Wilinska ME; Chassin LJ; Schaller HC; Schaupp L; Pieber TR; Hovorka R IEEE Trans Biomed Eng; 2005 Jan; 52(1):3-12. PubMed ID: 15651559 [TBL] [Abstract][Full Text] [Related]
25. Insulin-mediated glucose disposal in type 1 (insulin-dependent) diabetic subjects treated by continuous subcutaneous or intraperitoneal insulin fusion. Beylot M; Khalfallah Y; Laville M; Sautot G; Dechaud H; Serusclat P; Berthezene F; Riou JP; Mornex R Diabete Metab; 1987; 13(4):450-6. PubMed ID: 3315766 [TBL] [Abstract][Full Text] [Related]
26. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients. Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727 [TBL] [Abstract][Full Text] [Related]
27. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies. Olsson PO Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929 [TBL] [Abstract][Full Text] [Related]
28. Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study. Cernea S; Kidron M; Wohlgelernter J; Raz I Clin Ther; 2005 Oct; 27(10):1562-70. PubMed ID: 16330292 [TBL] [Abstract][Full Text] [Related]
29. The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus. Shichiri M; Kawamori R; Hakui N; Asakawa N; Yamasaki Y; Abe H Biomed Biochim Acta; 1984; 43(5):561-8. PubMed ID: 6477542 [TBL] [Abstract][Full Text] [Related]
30. A semi-closed loop computer-assisted insulin infusion system. Hospital use for control of diabetes in patients. Chisholm DJ; Kraegen EW; Bell DJ; Chipps DR Med J Aust; 1984 Dec 8-22; 141(12-13):784-9. PubMed ID: 6503781 [TBL] [Abstract][Full Text] [Related]
31. Intraindividual comparison of pharmacokinetics of insulin after intravenous, portal, subcutaneous and peritoneal administration. Fritze K; Fischer U; Freyse EJ; Besch W Exp Clin Endocrinol; 1988 Mar; 92(3):297-306. PubMed ID: 3075553 [TBL] [Abstract][Full Text] [Related]
32. Estimation of individually adapted control parameters for an artificial beta cell. Salzsieder E; Albrecht G; Jutzi E; Fischer U Biomed Biochim Acta; 1984; 43(5):585-96. PubMed ID: 6383363 [TBL] [Abstract][Full Text] [Related]
34. Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric. Palerm CC; Zisser H; Bevier WC; Jovanovic L; Doyle FJ Diabetes Care; 2007 May; 30(5):1131-6. PubMed ID: 17303792 [TBL] [Abstract][Full Text] [Related]
35. Tracer kinetic studies of glucose and alanine metabolism in diabetic dogs on the artificial beta cell. Freyse EJ; Fischer U; Albrecht G Biomed Biochim Acta; 1984; 43(5):607-14. PubMed ID: 6477544 [TBL] [Abstract][Full Text] [Related]
36. Efficacy comparison between preprandial and postprandial insulin aspart administration with dose adjustment for unpredictable meal size. Jovanovic L; Giammattei J; Acquistapace M; Bornstein K; Sommermann E; Pettitt DJ Clin Ther; 2004 Sep; 26(9):1492-7. PubMed ID: 15531011 [TBL] [Abstract][Full Text] [Related]
37. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies. Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887 [TBL] [Abstract][Full Text] [Related]
38. An insulin infusion advisory system based on autotuning nonlinear model-predictive control. Zarkogianni K; Vazeou A; Mougiakakou SG; Prountzou A; Nikita KS IEEE Trans Biomed Eng; 2011 Sep; 58(9):2467-77. PubMed ID: 21622071 [TBL] [Abstract][Full Text] [Related]